Drug intelligence / Profile preview

Siglec15

Development stage
Preclinical
Lead developer
NextCure
Modality
Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous, Subcutaneous
01

Overview

Siglec15 is a membrane-bound lectin and an immunosuppressive transmembrane protein that functions as an inhibitory immune checkpoint. It plays a crucial role in regulating inflammatory processes, promoting cancer development by repressing T lymphocyte activation and proliferation, and facilitating tumor cell immune escape. Siglec15 is also implicated in osteoclast differentiation and bone remodeling. Its expression is often upregulated in various cancer types and is associated with an immunosuppressive tumor microenvironment, making it a significant target for novel immunotherapies.

Other names
SIGLEC15SIGLEC-15SIGLEC 15
02

Targets

SIGLEC15 (Sialic acid-binding immunoglobulin-like lectin 15)

Beyond the preview

Go deeper on Siglec15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siglec15.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call